Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue
Njira Lugogo,1 Ileen Gilbert,2 Michael Pollack,2 Hitesh Gandhi,2 Joseph Tkacz,3 Miguel J Lanz4 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA; 2BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA; 3Inovalon, Bowie, MD, U...
Main Authors: | Lugogo N, Gilbert I, Pollack M, Gandhi H, Tkacz J, Lanz MJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-05-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/estimating-inhaled-corticosteroid-exposure-from-short-acting-2-agonist-peer-reviewed-fulltext-article-JAA |
Similar Items
-
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
by: Wittbrodt ET, et al.
Published: (2018-12-01) -
Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01) -
EARLY PRESCRIPTION OF INHALATION CORTICOSTEROID IN BRONCHIAL ASTHMA
by: Z. R. Aisanov, et al.
Published: (2017-11-01) -
Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
by: Faeq R. Kukhon, et al.
Published: (2021-05-01) -
DENTAL HEALTH IN ASTHMATICS TREATED WITH INHALED CORTICOSTEROIDS AND LONG-ACTING SYMPATHICOMIMETICS.
by: Emilia Karova, et al.
Published: (2012-06-01)